NCT04445857View on ClinicalTrials.gov

Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine in Spinal Anesthesia in Tramadol-abuse Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Analgesia
Interventions
DRUG

Calcitonin presented as Miacalcic® ampoules 100 IU/ml (1ml) intrathecally

coadministration of calcitonin intrathecally and a single-shot hyperbaric bupivacaine

DRUG

Calcitonin presented as Miacalcic® ampoules 100 IU/ml (1ml) intravenously

coadministration of calcitonin intravenously and a single-shot hyperbaric bupivacaine

OTHER

Normal Saline (NS)

coadministration of normal saline and a single-shot hyperbaric bupivacaine

Trial Locations (1)

Unknown

Ain-Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04445857 - Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine in Spinal Anesthesia in Tramadol-abuse Patients | Biotech Hunter | Biotech Hunter